Yongxiang Zhao
Guangxi Medical University(CN)Shanxi University(CN)Jiangsu Academy of Agricultural Sciences(CN)Shanghai Children's Medical Center(CN)Theranostics (New Zealand)(NZ)Ministère de l'Agriculture et de la Souveraineté alimentaire(FR)Cancer Clinic(US)Ministry of Science ICT and Future Planning(KR)Ministry of Agriculture(CA)Shanxi University of Traditional Chinese Medicine(CN)Shanghai Children's Hospital(CN)Zhejiang University(CN)Yangzhou University(CN)Taiyuan University of Technology(CN)
Publications by Year
Research Areas
Virus-based gene therapy research, Advanced biosensing and bioanalysis techniques, Immunotherapy and Immune Responses, RNA Interference and Gene Delivery, Nanoplatforms for cancer theranostics
Most-Cited Works
- → Therapeutic siRNA: state of the art(2020)1,446 cited
- → Heritable gene targeting in the mouse and rat using a CRISPR-Cas system(2013)648 cited
- → METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes(2019)533 cited
- → Oxygen-Self-Produced Nanoplatform for Relieving Hypoxia and Breaking Resistance to Sonodynamic Treatment of Pancreatic Cancer(2017)453 cited
- → Biodegradable Charge‐Transfer Complexes for Glutathione Depletion Induced Ferroptosis and NIR‐II Photoacoustic Imaging Guided Cancer Photothermal Therapy(2021)217 cited
- → Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen‐specific immunotherapy in patients with MUC1‐positive advanced cancer(2003)172 cited